Answers are grounded in this paper and cite their sources.
Laser photocoagulation has been an integral part of the management of diabetic macular edema (DME) for decades. And despite the dramatic changes in retinal imaging and the availability of new treatment options over the years it is still has a role in the pharmacotherapy era. First, as a supplementary treatment in eyes with CI-DME inadequately responding to antiVEGFs and steroids; to reduce the number and frequency of injections. And secondly, it is the only scientifically proven option for eyes with non CIDME with CSME features.
No takes yet. Share an insight, caveat, or question.
Tamer A. Macky (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: